Spatial navigation and APOE in amnestic mild cognitive impairment

Area of Science:

• Neuroscience
• Genetics
• Cognitive Science

Background:

• The impact of the Apolipoprotein E ε4 allele (ε4) on spatial navigation abilities in individuals with amnestic mild cognitive impairment (aMCI) remains largely unexplored.
• Understanding this relationship is crucial for early detection and intervention strategies.

Purpose of the Study:

• To investigate and characterize the spatial navigation performance differences between ε4-positive (ε4+) and ε4-negative (ε4-) aMCI patient subgroups.
• To compare these subgroups with healthy controls and individuals with mild Alzheimer's disease (AD).

Main Methods:

• Stratified 34 aMCI patients into aMCI-ε4- (n=23) and aMCI-ε4+ (n=11) groups based on APOE genotype determined from blood samples.
• Included control (n=28) and mild AD (n=16) groups for comparison.
• Utilized a human analogue of the Morris water maze to assess both egocentric (body-centered) and allocentric (world-centered) spatial navigation.

Main Results:

• aMCI-ε4+ patients exhibited significantly poorer performance in both egocentric and allocentric spatial navigation tasks compared to aMCI-ε4- patients.
• Despite cognitive similarities, aMCI-ε4+ patients performed comparably to mild AD patients, while aMCI-ε4- patients performed similarly to controls on egocentric tasks.
• All aMCI groups demonstrated impaired spatial navigation learning, irrespective of ε4 allele presence.

Conclusions:

• Individuals with aMCI and the APOE ε4 allele show more severe spatial navigation deficits than those without the allele.
• Spatial navigation performance in aMCI-ε4+ patients closely mirrors that of individuals with mild AD.
• While the ε4 genotype influences spatial navigation, it does not predict learning capacity in aMCI.
• Spatial navigation assessment holds promise for identifying individuals within the heterogeneous MCI population who are at increased risk for developing AD.